⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATRA News
Atara Biotherapeutics, Inc
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
globenewswire.com
ATRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
accessnewswire.com
ATRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
accessnewswire.com
ATRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
accessnewswire.com
ATRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
accessnewswire.com
ATRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
accessnewswire.com
ATRA
PIERRE FABRE PHARMACEUTICALS STATEMENT REGARDING RECEIPT OF COMPLETE RESPONSE LETTER FOR TABELECLEUCEL BIOLOGICS LICENSE APPLICATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION
prnewswire.com
ATRA
Atera Named a Visionary in 2026 Gartner® Magic Quadrant™ for Endpoint Management Tools
prnewswire.com
ATRA
Senior Living Providers Experience Major Year-Over-Year Gains in Satisfaction Despite Rising Costs, J.D. Power Finds
businesswire.com
LCS
DSC
FVE
ATRA
FRNT
Pierre Fabre Pharmaceuticals Announces Transfer from Atara Biotherapeutics of the Biologics License Application (BLA) for Tabelecleucel as Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
prnewswire.com
ATRA